A recent study proposed that BBB breakdown is an early biomarker of human cognitive dysfunction independent of amyloid-β (Aβ) and tau, which are classic Alzheimer’s disease (AD) biomarkers [7]. The gene discussed is MAPT; the disease is Alzheimer disease.